Back
#1
31.0%
Top 8%
15.9%
Top 0.2%
9.8%
Top 70%
7.0%
Top 0.2%
7.0%
Top 11%
3.3%
Top 7%
3.0%
Top 4%
2.1%
Top 0.7%
1.7%
Top 45%
1.5%
Top 3%
1.5%
Top 26%
1.0%
Top 5%
1.0%
Top 16%
0.8%
Top 19%
0.8%
Top 15%
0.8%
Top 28%
0.8%
Top 9%
0.8%
Top 6%
0.8%
Cost-effectiveness of High-Dose Influenza Vaccination in the Netherlands: Updated Analysis Incorporating New Evidence
2026-02-18
health economics
Title + abstract only
View on medRxiv
Show abstract
BackgroundHigh-dose inactivated influenza vaccination (HD-IIV) demonstrates superior effectiveness versus standard-dose vaccination (SD-IIV) in adults aged [≥]60 years. A recent meta-analysis integrated complementary evidence sources of representing over 85 million individuals across 14 influenza seasons. MethodsA previously developed model was updated using life-time horizon and societal perspective. Updated parameters included demographics, costs, hospitalization rates, and relative vaccin...
Predicted journal destinations
1
Vaccine
140 training papers
2
BMJ Open
553 training papers
3
BMC Medicine
155 training papers
4
PLOS ONE
1737 training papers
5
PLOS Medicine
95 training papers
6
Clinical Infectious Diseases
219 training papers
7
BMJ Global Health
95 training papers
8
Vaccines
131 training papers
9
eClinicalMedicine
55 training papers
10
Nature Communications
483 training papers
11
The Lancet Infectious Diseases
57 training papers
12
BMC Public Health
148 training papers
13
BMC Health Services Research
43 training papers
14
The Journal of Infectious Diseases
137 training papers
15
Proceedings of the National Academy of Sciences
100 training papers
16
Open Forum Infectious Diseases
124 training papers
17
JAMA Network Open
125 training papers
18
American Journal of Epidemiology
54 training papers
19
BMJ
49 training papers